Skip to main content

Blogs

Recent Posts

Select Topic

CDC's Gerberding resigns; temporary FDA commish named

Two developments from the land of presidential transition: Julie Gerberding resigned as chief of the Centers for Disease Control and Prevention (CDC) after six-plus years in the post, and Frank Torti, principal deputy commissioner at the Food and Drug Administration (FDA), becomes the agency's acting commish next week to pave the way for new Obama administration appointees.

January 12, 2009 — Jordan Lite

Tonight's perigee moon in photos

If you're watching the snow come down in the northeastern U.S., like we are here at 60-Second Science, you probably can't see tonight's perigee moon, which we posted about earlier.

January 10, 2009 — Ivan Oransky

Will DTV transition be delayed?

Lovers of analog TV may get a reprieve from the scheduled February 18 transition to digital television. President-elect Barack Obama wants to delay next month's nationwide transition, arguing that there isn’t enough money to back the program.

January 9, 2009 — Jordan Lite

Can open-heart surgery make you dimmer?

Every year, about half a million Americans undergo open-heart surgery. Roughly 60 percent of them experience some degree of mental decline after the surgery, a phenomenon that surgeons call "pumphead." A new study in this month's Annals of Thoracic Surgery sheds light on possible causes of the mysterious condition, which in some patients is temporary but in others may last a lifetime.

January 9, 2009 — Coco Ballantyne

Don't have a cow, but FDA could approve goat-made medicine

Some consumer groups are bleating over the prospect of a new anti-clotting drug made from genetically modified goats.

An advisory committee to the Food and Drug Administration (FDA) is meeting today to discuss whether to recommend approval of ATryn, a med made from the milk of goats engineered to produce copious amounts of the blood-thinning protein antithrombin.

January 9, 2009 — Jordan Lite

Blog Index

Why Do Facts Fail?

Why Do Facts Fail?

Deconstructing Denial